Progressive Metastatic Castrate Resistant Prostate Cancer
3 clinical trials · Condition
◉ Watch Progressive Metastatic Castrate Resistant Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. (NCT04495179) | AstraZeneca | 2020-08-04 |
| Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib (NCT03386071) | Jonsson Comprehensive Cancer Center |
Track Progressive Metastatic Castrate Resistant Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.